Topic Archives: phosphate

Those of you who’ve been around these parts for a while probably know that I think food and agriculture are likely to be important investment sectors in the decades to come — there’s simply no getting around the fact that the population continues to rise and arable land declines, which means the produce of that […]

Comments

  • Gr8Full!

    $MGEN wow abstracts > :-) Improved Perfusion and Wound Healing in Healthy Pigs With MRG-110, an Inhibitor of MicroRNA-92...

  • Avatar

    $ CUR NP Neuralstem presents updated data from Phase 2 Study of NSI-189 Neuralstem announced that additional safety...

  • Avatar

    Oh, I forgot to mention that the Lithium Iron Phosphate (LiFePO4) battery is very popular in China, where it is produced...

  • Avatar

    Hi Griffin, Thank you and I'm with you on everything. I have been looking into all of these topics. The use of Iron Ph...

  • Avatar

    In case any of you (including e-subscribers to my newsletter and other who like to learn from my work without paying, we...

  • SoGiAm

    $NNOMF - Nano One Files Lithium Iron Phosphate Patent https://nanoone.ca/nano-one-files-lithium-iron-phosphate-patent/...

  • Avatar

    That is why I have begun looking at hard assets again HN. When I entered a few years back I had few clues which ones to ...

  • Avatar

    $NVAX. I took a long position close to lows yesterday. They have a read-out from the Phase 2 RSV vaccine trial in older ...

  • Avatar

    $CUR -- New publication out. You need a subscription to access the entire article. Here's an abstract: Expert Opinion...

  • Avatar

    $CUR -- This just popped up on my Fidelity screen. Expect to see some follow-through pps increase tomorrow. Neuralste...

  • Avatar

    $LFVN Np - I do not know much about this company other than it claims to slow down the aging process internally and ex...

  • JohnM

    $KERX long. There are 16 million US adults with chronic kidney disease. 2.2 million of those seeing a nephrologist – K...

  • Avatar

    "Auryxia can bind to phosphate in the gastrointestinal tract and form non-absorbable complexes to reduce intestinal abso...

  • Avatar

    $KERX long. I have to ask the medically knowledgeable about this one. Keryx has one product, Auryxia, a phosphate bind...

  • Avatar

    $RGLS Thank you Dr.KSS so much for your explanation of science issues facing RGLS. I will reread your article again (alr...

  • JohnM

    Keryx Pharmaceuticals introduced Auryxia last year for binding phosphate in dialysis patients. It also increases iron st...

  • Dr. KSS MD PhD

    Thanks Phil. Please note that in my view, one person's opinion, Ardelyx is not a bad stock to be in. I have no position ...

  • Avatar

    Thanks richardo, adding to what you have said here is a pretty thorough breakdown of NSI-189 phosphate by a patient who ...

  • Avatar

    Well, my project is to build an off grid community, so the place I found here in the US was Elecyr (like Elixer). Fully...

  • Avatar

    Here is the long version: Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), a biopharmaceutical company focused on developi...

  • Avatar

    Those that hype these products are either unable to distinguish between "technically possible" and "economically feasibl...

  • Myron Martin

    Interesting, I resubscribed to Early Advantage after 6 months of "badgering" for $59. and just to-day received for the T...

  • Dr. KSS, MD PhD

    Om: about Mirati Therapeutics $MRTX, certainly the recent bolus of institutional buying including the large chunk by Box...

  • Avatar

    Good news for CPRX Catyalyst Pharmaceutical (NASDAQ: CPRX) announced positive top-line results from the pivotal Phase...

  • Dr. KSS, MD PhD

    Thanks for the update Booya. Personally, it doesn't do much for me. There are other perfectly good oral phosphate binder...

  • Dr. KSS, MD PhD

    That's a pretty ZOMG paper, Om. Wow! PTEN is a phosphatase, something that does the opposite of what kinases do. Kina...

  • John Murphy

    Dr. KSS - Zerenex both lowers elevated phosphate levels in dialysis patients AND reduces Erythropoiesis-Stimulating Agen...

  • Dr. KSS, MD PhD

    Travis, Zerenix is a phosphate binder for people in renal failure on dialysis. The kidney normally clears excessive phos...

  • jer_vic

    2 more ideas: 1) Mannkind (MNKD) July calls. They have a PDUFA coming up on July 15th for Afrezza. ADCOM has voted ...

  • analog68

    I have seen price target raised on KERX again, now up to $30. It was mentioned a while back at $15, having a price targ...

  • frank archambeau

    330 4hl; Do you know name of Idaho phosphate prospect & if is traded? I would appreciate your info. Thanks....

  • Avatar

    I'm not sure phosphate is the most critical nutrient but I do agree it might be the most interesting investment; as you ...

  • Travis Johnson, Stock Gumshoe

    Nitrogen is cheap to produce when natural gas is cheap, so the nitrogen producers might have had trouble with margins re...

  • jer_vic

    Anti-Infective Drugs Advisory Committee meeting on Mar. 31 to discuss the NDA of dalbavancin (afternoon session). https...

  • karma swim swami

    It's fascinating re;starvation. Annals of Internal Medicine last week ran three original studies (one a metanalysis of o...

  • Avatar

    Perhaps an interesting point to make for those of you who spend a lot of time flying in airliners (either as crew or pas...

  • Avatar

    Kresser's bio and introduction: He seems to be well versed in alternative/complimentary medicine but his bio - credenti...

  • Avatar

    Personally, I much prefer the "picks and shovels" approach to the whole agriculture investing niche. I rather...

  • Avatar

    I'm watching both of those companies (Legend and Stonegate) and would like to someday throw some money directly into a p...

  • Avatar

    Hidy Ho Neighbour, I like the idea of investing in an emerging African based company, but Lonrho is not available wi...

  • Avatar

    Just another Doc who looked up your suggestion...This is not so natural either and in addition not really comparable to ...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch